Description
Roxithromycinisasemi-syntheticmacrolideantibioticthatexhibitsanti-inflammatory,anti-asthma,vasodilatory,antibacterial,andanti-arthriticactivities;itbindstothe50Sribosome,inhibitingproteinsynthesis.Inanimalmodelsofovalbumin-inducedasthma,roxithromycindecreasesthenumberofinflammatorycellsandairwayhyperresponsivenessandsuppresseslevelsofIgE,inflammatorycytokines,andactivatedNF-κB.Roxithromycinalsoinducesvascularrelaxationexvivoinarteriesandthoracicaortasegments.Inmacrophages,thiscompoundinhibitsTcellproductionofTNF-αandIL-6;inanimalmodelsofarthritis,itinhibitsTcellmigrationanddecreasesdiseaseseverity.
References
CiX,ChuX,XuX,etal.Short-termroxithromycintreatmentattenuatesairwayinflammationviaMAPK/NF-κBactivationinamousemodelofallergicasthma.InflammRes.2012Jul;61(7):749-58.PMID:22481373.
BiavaM,PorrettaGC,DeiddaD,etal.Newtrendsindevelopmentofantimycobacterialcompounds.InfectDisordDrugTargets.2006Jun;6(2):159-72.PMID:16789877.
UrasakiY,NoriM,IwataS,etal.RoxithromycinspecificallyinhibitsdevelopmentofcollageninducedarthritisandproductionofproinflammatorycytokinesbyhumanTcellsandmacrophages.JRheumatol.2005Sep;32(9):1765-74.PMID:16142877.
BermanM,HasdaiD,RaananiE,etal.Ex-vivoeffectofroxithromycinonhumanandratarterialvasoactivity.InteractCardiovascThoracSurg.2005Jun;4(3):232-7.PMID:17670399.